Close Menu

NEW YORK – A. Menarini Diagnostics and Credo Diagnostics Biomedical announced on Thursday an exclusive distribution agreement for Credo's SARS-CoV-2 assay kit and other assays for diagnosing respiratory syncytial virus and Group Strep A.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.